Kümmerle-Deschner, J., Kallinich, T., Henes, J., Kortus-Götze, B., Oommen, P., Rech, J., . . . Blank, N. (2024). Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: Results from the interim analysis of the RELIANCE registry. RMD Open, 10(1), . https://doi.org/10.1136/rmdopen-2023-003890
Chicago Style (17th ed.) CitationKümmerle-Deschner, Jasmin, et al. "Long-term Safety and Effectiveness of Canakinumab in Patients with Monogenic Autoinflammatory Diseases: Results from the Interim Analysis of the RELIANCE Registry." RMD Open 10, no. 1 (2024). https://doi.org/10.1136/rmdopen-2023-003890.
MLA (9th ed.) CitationKümmerle-Deschner, Jasmin, et al. "Long-term Safety and Effectiveness of Canakinumab in Patients with Monogenic Autoinflammatory Diseases: Results from the Interim Analysis of the RELIANCE Registry." RMD Open, vol. 10, no. 1, 2024, https://doi.org/10.1136/rmdopen-2023-003890.